Efficacy and safety of degludec U100 versus glargine U300 for the early postoperative management of patients with type 2 diabetes mellitus undergoing coronary artery bypass graft surgery: A non-inferiority randomized trial.

Diabetic medicine : a journal of the British Diabetic Association(2023)

引用 1|浏览6
暂无评分
摘要
Treatment with degludec U100 is as effective and safe as glargine U300 for the early postoperative hospital management of patients with T2D undergoing CABG.
更多
查看译文
关键词
continuous glucose monitoring system,degludec U100,glargine U300,hospital care,hypoglycemia,inpatient management
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要